Formulation and evaluation of xanthan gum based aceclofenac tablets for colon targeted drug delivery

Brazilian Journal of Pharmaceutical Sciences

Volumn 47, Issue 2, 2011, Pages 299-311

  Ramasamy, Thiruganesh ^a,d   Kandhasami, Uma Devi Subbaih ^b,c   Ruttala, Himabindhu ^d   Shanmugam, Suresh ^b  

^a Utah Inha DDS and Advanced Theapeutics Research Center   (South Korea)

^b VELS INSTITUTE OF SCIENCE   (India)

^c Raos College of Pharmacy   (India)

^d Pydah College of Pharmacy   (India)

Author keywords

Aceclofenac release colon targeted; Colon targeting; Drugs release colon targeted; Eudragit coating; In vitro dissolution; Targeted delivery; Xanthan gum

Indexed keywords

ACECLOFENAC; BACTERIAL ENZYME; EUDRAGIT; XANTHAN;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG COATING; DRUG DELIVERY SYSTEM; ENZYMATIC DEGRADATION; IN VITRO STUDY; INFRARED SPECTROSCOPY; INTESTINE FLUID; NONHUMAN; RAT; SIMULATION; STOMACH JUICE; TABLET FORMULATION; TABLET HARDNESS; TABLET PROPERTY;

EID: 84860401861     PISSN: 19848250     EISSN: 21759790     Source Type: Journal    
DOI: 10.1590/S1984-82502011000200011     Document Type: Article

References (49)

1. AKANKSHA, T.; RAJ KUMAR, S. Natural polymer in colon targeting. Int. J. Pharm. Clin. Res., v.1, n.2, p. 43-46, 2009.
2. AULTON, M.E.; WELLS, J.I. Pharmaceutics. The science of dosage form design. London: Churchill Livingstone, 1988. p.247-249.
3. AVACHAT, A.; KOTWAL, V. Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate. AAPS PharmSciTech., v.8, n.4, p.88-96, 2007.
4. BI, Y.; SUNADA, H.; YONEZAWA, Y.; DANJO, K.; OTSUKA, A.; LIDA, K. Preparation and evaluation of a compressed tablet rapidly disintegrating in oral cavity. Chem. Pharm. Bull., v.44, n.11, p.2121-2127, 1996.
5. CARR, R.L. Evaluating flow properties of solids. Chem. Eng., v.72, n.3, p.163-168, 1965.
6. CHOURASIA, M.K.; JAIN, S.K. Pharmaceutical approaches to colon targeted drug delivery systems. J. Pharm. Sci., v.6, n.1, p.33-36, 2003.
7. DHAWALE, S.C.; BANKAR, A.S.; PATRO, M.N. Formulation and Evaluation Porous Microspheres of 5- Fluorouracil for Colon Targeting. Int. J. Pharm. Tech. Res., v.2, n.2, p.1112-1118, 2010.
8. MEDICINE ONLINE. Diclofenac Sodium Delayed-release Tablets, USP. Available at: http://www.medicineonline.com/drugs/d/2288/Diclofenac-Sodium-Delayed-release-TabletsUSP.html. Accessed on: 14. jun. 2010
9. DRUG DETAILS. EPG Mobile beta. Available at: http://www.epgonline.org/mobile/drug-details.cfm/id/DR004273/page/atoz/letter/a/language/LG0001/startrow_drug/1/drugName/Aceclofenac-100-mg-Tablets. Accessed on: 13 may 2010.
10. DHOPESHWARKAR, V.; O'Keeffe, J.C.; HORTON, M. Development of an oral sustained release antibiotic matrix tablet using invitro/invivo correlations. Drug Develop. Ind. Pharm., v.20, n.11, p.1851-1867, 1994.
11. FLORENCE, A.T.; ATTWOOD, D. Physicochemical principles of pharmacy. 3.ed. London: Macmillan Press Ltd., 1998. H48. p.5-85.
12. GANG CHENG; FENG AN; Mei-Juan ZOU; JIN SUN; Xiu-Hua HAO; Yun-Xia HE. Time- and pH- dependent colon-specific drug delivery for orally administered diclofenac sodium and 5- aminosalicylic acid. World J. Gastroenterol., v.10, n.12, p.1769-1774, 2004.
13. GOHEL, M.C.; BANSAL, G.; BHATT, N. Formulation and evaluation of orodispersible taste masked tablets of famotidine. Pharm. Biol. World, v.3, n.6, p.75-80, 2005.
14. MEHRGAN, H.; MORTAZAVI, S.A. The release behavior and kinetic evaluation of diltiazem HCL from various hydrophilic and plastic based matrices. Iran J. Pharm. Res., v.3, n.3, p.137-146, 2005.
15. HALSAS, M.; Hietala, J.; VESKI, P.; JURJENSON, H.; MARVOLA, M. Morning versus evening dosing of ibuprofen using conventional and time controlled release formulations. Int. J. Pharm., v.189, n.2, p.179-185, 1999.
16. HALSAS, M.; PENTTINEN, T.; VESKI, P.; JURJENSON, H.; MARVOLA, M. Time controlled release pseudoephedrine tablets: bioavailability and in vitro/in vivo correlations. Pharmazie, v.56, n.114, p.718-723, 2001.
17. HAUSNER, H.H. Friction conditions in a mass of metal powder. Int. J. Metall., v.3, n.9, p.7-13, 1967.
18. KAY, A.E.; ALLDRED, A. Rheumatoid arthritis and osteoarthritis. In: WALKER, R., EDWARDS, C. (Eds.). Clinical pharmacy and therapeutics. 3.ed. London: Churchill Livingstone, 2003. p.791-807.
19. KINCL, M.; VREVER, F.; VEBER, M. Characterization of factors affecting the release of low-solubility drug from prolonged release tablets. Anal. Chim. Acta., v.502, n.7, p.107-113, 2004.
20. KINGET, R.; KALALA, W.; VERVOORT, L.; Van Den Mooter, G. Co- lonic drug targeting. J. Drug Target., v.6, n.2, p.129-149, 1998.
21. LACHMAN, L.; LIEBERMAN, H.A.; KANIG, J.L. The theory and practice of industrial pharmacy. 3.ed. Mumbai: Varghese Publishing House, 1987. p.182-184, 296-303, 311-312.
22. LEHMANN, K.O.R.; DREHER, K.D. Methacrylate-galactomannan coating for colon-specific drug delivery. Proc. Int. Symp. Control. Rel. Bioact. Mater., v.18, n.194, p.331-332, 1991.
23. LIU, L.; FISHMAN, M.L.; KOST, J.; HICK, K.B. Chondroitin sulphate based systems for colon - specific drug delivery via oral route. Biomaterials, v.246, n.3, p.3333-3343, 2003.
24. MANEK, N. J.; LANE, N.E. Osteoarthritis: Current Concepts in Diagnosis and Management. Am. Fam. Physician, v.61, n.12, p.1795-804, 2000.
25. MOMIN, M.; PUNDARIKAKSHUDU, K. In vitro studies on guar gum based formulations for the colon targeted delivery of sennosides. J. Pharm. Pharmaceut., v.7, n.3, p.325-331, 2004.
26. MOSKOWITZ, R.W. The role of anti-inflammatory drugs in the treatment of osteoarthritis: a United States viewpoint. Clin. Exp. Rheumatol., v.19, n.6, p.S3-S8, 2001.
27. MUNDARGI, R.C.; PATIL, S.A.; AGNIHOTRI, S.A.; AMINABHAVI, T.M. Development of polysaccharide-based colon targeted drug delivery systems for the treatment of amoebiasis. Drug Dev. Ind. Pharm., v.33, n.3, p.255-264, 2007.
28. MUTALIK, S.; MANOJ, K.; Sreenivasa Reddy, M.; KUSHTAGI, P.; Nayak Usha, A.; ANJU, P.; Kumar Ranjith, A.; UDUPA, N. Chitosan and enteric polymer based once daily sustained release tablets of Aceclofenac: in vitro and in vivo studies. AAPS PharmSciTech., v.9, n.2, p.651-659, 2007.
29. NSAIDs for Rheumatoid Arthritis. Rheumatoid arthritis guide. Available at: http://www.webmd.com/rheumatoid-arthritis/guide/nsaids-rheumatoid-arthritis. Accessed on: 12. april 2009.
30. NTAWUKULILYAYO, J.D.; VERVAET, C.; REMON, J.P.; GÖRTZ, J.P.; BERLO, J.A. In vitro and in vivo evaluation of a xanthan gum-n-octenylsuccinate starch matrix tablet containing ibuprofen as a model containing ibuprofen as a model drug. Int. J. Pharm., v.139, n.2, p.79-85, 1996.
31. PAHARIA, A.; YADAV, A.K.; RAI, G.; JAIN, S.K.; PANCHOLI, S.S.; AGRAWAL, G.P. Eudragit-coated chondroitin sulphate microspheres of 5-fluorouracil for colon targeting. AAPS PharmSciTech., v.8, n.1, p.135-146, 2007.
32. PARFITT, K. Analgesics, anti-inflammatory and antipyretics. In: REYNOLDS, J.E.F. (Ed.). MARTINDALE: The complete drug reference. 32.ed. Massachusetts, London: Pharmaceutical press, 1999. p.1-12.
33. RAVI KUMAR; PATIL, M.B.; PATIL, S.R.; MAHESH S.P. Polysaccharides based colon specific drug delivery: A Review. Int. J. Pharm. Tech. Res., v.1, n.2, p.334-346, 2009.
34. RAJASEKHARAN, T.; PALANICHAMY, S.; SHANMUGANATHAN, S.; KARTHIKEYAN, A.; SENTHILKUMAR, S.R.; THIRUPATHI, T. Formulation and Evaluation of Theophylline Controlled Release Matrix Tablets using Xanthan gum. Der Pharm. Let., v.1, n.2, p.93-101, 2009.
35. SALYERS, A.A.; VERCELLOTTI, J.R.; WEST, S.H.E.; WILKINS, T.D. Fermentation of mucin and plant polysaccharides by strains of bacteroides from the human colon. Appl. Environ. Microbiol., v.33, n.2, p.319-322, 1977.
36. SARASIJA, S.; HOTA, A. Colon-specific drug delivery systems. Ind. J. Pharm. Sci., v.62, n.1, p.1-8, 2000.
37. SHEU, M.; CHOU, H.; KAO, C.; LIU, C.; SOKOLOSKI, T.D. Dissolution of diclofenac sodium from matrix tablets. Int. J. Pharm., v.85, n.1-3, p.57-63, 1992.
38. SINHA, V.R.; MITTAL, B.R.; BHUTANI, K.K.; RACHNA KUMARI. Colonic drug delivery of 5 fluorouracil: an in vitro evaluation. Int. J. Pharm., v.269, n.1, p.101-108, 2004.
39. SINHA, V.R.; ASMITA SINGH.; SANJAY SINGH.; BHINGE, J.R. Compression coated systems for colonic delivery of 5-fluorouracil. J. Pharm. Pharmacol., v.59, n.3,p.359-365, 2007.
40. SWARBRICK, J. Encyclopedia of pharmaceutical technology. 3.ed. New York: Informa healthcare, 2007. v.6, p.2614-2629.
41. TALUKDAR, M.M.; KINGE, R. Swelling and drug release behaviour of xanthan gum matrix tablets. Int. J. Pharm., v.120, n.1, p.63-72, 1995.
42. TRAIN, D. Some aspects of the property angle of repose of powders. J. Pharm. Pharmacol., v.10, n.11, p.127-135, 1958.
43. UNITED STATES PHARMACOPOEIA. 24-NF-19. Rockwille: US Pharmacopeial Convention, 1999. p.587-598.
44. UNITED STATES PHARMACOPOEIA. XXVII. Rockville: US Pharmacopeial Convention, 2004. p.2300-2304.
45. UNITED STATES PHARMACOPOEIA, 19th ed., 2008. Available at: http://www.usp.org. Accessed on: 9th Sep 2009.
46. VAIDYA, A.; JAIN, A.; KHARE, P.; AGRAWAL, R.K.; JAIN, S.K.; Metronidazole loaded pectin microspheres for colon targeting. J. Pharm. Sci., v.98, n.11, p.4229-4236, 2009.
47. YANG, L.; CHU, J.S.; FIX, J.A. Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int. J. Pharm., v.235, n.1, p.1-15, 2002.
48. YEOLE, P.G.; GALGATTE, U.C.; BABLA, I.B.; NAKHAT, P.D. Design and evaluation of Xanthan gum-based sustained release Matrix tablets of Diclofenac sodium. Ind. J. Pharm. Sci., v.68, n.2, p.185-189, 2006.
49. WATTS, P.J.; ILLUM, L. Colonic drug delivery. Drug Dev. Ind. Pharm., v.23, n.9, p.893-913, 1997.